18 subscribers
Go offline with the Player FM app!
Podcasts Worth a Listen
SPONSORED


1 You Are Your Longest Relationship: Artist DaQuane Cherry on Psoriasis, Art, and Self-Care 32:12
Predetermined Change Control Plans, Part 2
Manage episode 441574798 series 2805302
In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we continue speaking on the topic of predetermined change control plans. Potential scenarios for their use are discussed, examples are provided, and role of PCCPs for manufacturing processes are explored. If you haven’t yet listened to Part 1, click here to do so. Specifically, the following questions are addressed in part 2:
- You have submitted a PCCP with a previous regulatory submission, but you have not yet made the actual, real-world change to the device. Can that PCCP submission, assuming it was approved, be used as a predicate for a 510k submission?
- For what types of devices should I consider a PCCP?
- Can you provide a few examples of PCCPs?
- Can PCCPs be used for manufacturing?
- Since the use of a PCCP is relatively new, can you think of what questions could potentially arise? What questions might we not have just yet?
- Anything else you’d like to say about the use of a PCCP we haven’t covered?
- What are the important takeaways?
After both parts, do you have a better understanding of PCCPs? If you’d like to share thoughts, ask questions, or have a suggestion for a future topic for us to cover, please reach out to me at sfenske@rodmanmedia.com and we’ll see if we want to address your ideas/inquiries/suggestions in a future episode.
For more medtech news and information, visit https://www.mpomag.com.
153 episodes
Manage episode 441574798 series 2805302
In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we continue speaking on the topic of predetermined change control plans. Potential scenarios for their use are discussed, examples are provided, and role of PCCPs for manufacturing processes are explored. If you haven’t yet listened to Part 1, click here to do so. Specifically, the following questions are addressed in part 2:
- You have submitted a PCCP with a previous regulatory submission, but you have not yet made the actual, real-world change to the device. Can that PCCP submission, assuming it was approved, be used as a predicate for a 510k submission?
- For what types of devices should I consider a PCCP?
- Can you provide a few examples of PCCPs?
- Can PCCPs be used for manufacturing?
- Since the use of a PCCP is relatively new, can you think of what questions could potentially arise? What questions might we not have just yet?
- Anything else you’d like to say about the use of a PCCP we haven’t covered?
- What are the important takeaways?
After both parts, do you have a better understanding of PCCPs? If you’d like to share thoughts, ask questions, or have a suggestion for a future topic for us to cover, please reach out to me at sfenske@rodmanmedia.com and we’ll see if we want to address your ideas/inquiries/suggestions in a future episode.
For more medtech news and information, visit https://www.mpomag.com.
153 episodes
All episodes
×
1 3 Most Common Premarket (Postmarket?) Review Issues FDA Sees 51:44

1 Why Are One-Third of MAUDE Reports a Problem? 56:38

1 FDA Guidance on Off-Label Communication, Part 1 50:08

1 FDA Guidance on Off-Label Communication, Part 2 55:41

1 Development Considerations for Over-the-Counter Medtech, Part 1 47:21

1 Development Considerations for OTC Medtech, Part 2 59:44

1 Device Descriptions in Regulatory Submissions 51:34

1 Regulatory Ramifications Due to the Presidential Election 53:45

1 Regulatory Considerations with an Assisted Suicide Machine 50:41






1 The Most Dangerous Devices to Hit the Market 40:42

1 Headline-Generating Medical Device Safety Concerns 49:16

1 Analyzing ECRI’s 2024 Top 10 Health Technology Hazards 51:35


1 Reimbursing Breakthrough Designation Products 51:18




1 Can You Use a Recalled Device as a Predicate? 53:40

1 Leading Issues from FDA Inspections (or History Repeating Itself) 46:17

1 To Regulate or Not to Regulate…LDTs, Part 2 49:18

1 To Regulate or Not to Regulate…Lab Developed Tests, Part 1 42:03




1 FDA's Intended Use Rule’s Relation to Labeling 51:05

1 Gaining an Advantage Through Class II Special Controls 47:15


1 Initiating a Voluntary Medical Device Recall 47:21

1 Humacyte’s Bioengineered Tissue Platform Technology 27:37

1 Koya Medical Restores Mobility for Compression Therapy Patients 26:58

1 NeuroPace’s Aid in Tracking and Treating Epilepsy 20:00

1 Aidoc Is Improving Patient Outcomes Through AI 21:25

1 Performing a Gap Analysis on FDA's Regulatory Protocols 43:38

1 Stereotaxis’ Robotic Surgery System for Interventional Procedures 22:46

1 Fighting Tumors with Varian’s FLASH Technology 23:14

1 RSIP Vision’s Diagnostic Imaging Advancements 20:05



1 GE Healthcare’s Chief Digital Officer’s 2022 Predictions 29:30
Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.